Back

Frailty and obesity in heart transplant recipients: impact on post-transplant mortality

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Progress in advanced heart failure therapy Heart Transplantation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Thomas Goubar

St Vincents Hospital, Sydney (Australia)

5 More presentations in this session

Presentation thumbnail
Equivalent improvement in exercise capacity after mechanical circulatory support compared to heart transplant in advanced heart failure
Doctor H. Lo (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of HF pharmacological therapy on the durability of favorable response after LVAD weaning: a VAD wean registry analysis
Doctor S. Drakos (Salt Lake City, US)
Abstract Slides Video
Presentation thumbnail
Clinical impact of frailty after durable left ventricular assist device implantation
Doctor S. Kazama (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Impact of delayed heparin bridging on bleeding and stroke after heartmate 3 left ventricular assist device implantation
Mr P. Jahangiri (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of antithrombotic regimens in patients with durable left ventricular assist devices: a systematic review and bayesian network meta-analysis
Ms M. Ramos Miranda (BR)
Abstract Slides Video

Access the full session

Session thumbnail
Progress in advanced heart failure therapy
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Frailty status, aging, and mortality risk in heart failure
thumbnail
Congress Presentation
The impact of age, disease progression, depression, and hospitalization duration on frailty in patients with heart failure
thumbnail
Congress Presentation
Changes in frailty status over time and its impact on clinical outcomes after diagnosis of heart failure in primary care: population-based observational study in the UK

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources